Back to Search
LAUREN SCHWARTZBERG, DO
DO
Internal Medicine Physician
NPI: 1750965455Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
OT020610(PA)
Research & Publications (20)
Implications of IV monoclonal antibody infusion reaction for the patient, caregiver, and practice: results of a multicenter study.
PMID 18592276·Support Care Cancer·2009
4-observational
Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.
PMID 19342237·Breast·2009
8-other
Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer.
PMID 19148686·Support Care Cancer·2009
4-observational
A retrospective study of quality of life in a community sample of patients with early stage breast cancer.
PMID 19373552·Breast Cancer Res Treat·2009
8-other
Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
PMID 19273708·J Clin Oncol·2009
3-trial
A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
PMID 19404213·J Thorac Oncol·2009
3-trial
A phase II trial of pemetrexed and gemcitabine as first line therapy for poor performance status and/or elderly patients with stage IIIB/IV non-small cell lung cancer.
PMID 19167130·Lung Cancer·2009
3-trial
Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens.
PMID 19179558·Ann Oncol·2009
3-trial
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
PMID 18626004·J Clin Oncol·2008
3-trial
A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.
PMID 18520803·J Thorac Oncol·2008
3-trial
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.
PMID 18640933·J Clin Oncol·2008
4-observational
Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer.
PMID 18650153·Clin Breast Cancer·2008
3-trial
Retrospective chart review of severe infusion reactions with rituximab, cetuximab, and bevacizumab in community oncology practices: assessment of clinical consequences.
PMID 17909865·Support Care Cancer·2008
8-other
Symptom Burden for Patients with Metastatic Colorectal Cancer Treated with First-Line FOLFOX or FOLFIRI with and Without Bevacizumab in the Community Setting.
PMID 18632522·Support Cancer Ther·2007
8-other
Chemotherapy-induced nausea and vomiting: clinician and patient perspectives.
PMID 17366928·J Support Oncol·2007
6-review
Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: results of exploratory phase I/II trials in patients with metastatic melanoma.
PMID 17651037·Cancer Biother Radiopharm·2007
8-other
Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy?
PMID 17715696·Oncology (Williston Park)·2007
6-review
A prospective investigation of chemotherapy-induced neutropenia and quality of life.
PMID 17080736·J Support Oncol·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1200 S CEDAR CREST BLVD
ALLENTOWN, PA 18103 - Phone
- (610) 402-5100
Quick Facts
- NPI
- 1750965455
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile